Company intelligence / Profile preview

Rheogenx Biosciences

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

Rheogenx Biosciences is a pre-clinical stage biotechnology company focused on developing novel small molecule therapeutics for autoimmune and inflammatory diseases. The company leverages a proprietary platform to target Solute Carrier (SLC) transporters, a diverse class of membrane proteins that play critical roles in immune cell metabolism and signaling. By modulating these transporters, Rheogenx aims to restore immune homeostasis and provide new treatment options for patients with chronic inflammatory conditions. Founded by industry veterans and backed by Versant Ventures, the company is headquartered in San Diego, California.

Therapeutic areas: Immunology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Rheogenx Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rheogenx Biosciences.

Explore the full profile